Gateway Wealth Partners LLC Invests $691,000 in Cencora, Inc. $COR

Gateway Wealth Partners LLC acquired a new stake in Cencora, Inc. (NYSE:COR) during the 1st quarter, Holdings Channel.com reports. The firm acquired 2,198 shares of the company’s stock, valued at approximately $691,000.

A number of other large investors have also made changes to their positions in COR. Kemnay Advisory Services Inc. acquired a new position in Cencora in the 4th quarter valued at about $25,000. Oakworth Capital Inc. acquired a new stake in shares of Cencora during the 4th quarter worth about $26,000. Elyxium Wealth LLC purchased a new stake in shares of Cencora during the fourth quarter worth about $27,000. Archer Investment Corp grew its holdings in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock worth $28,000 after buying an additional 47 shares in the last quarter. Finally, Motiv8 Investments LLC purchased a new stake in shares of Cencora during the fourth quarter worth about $29,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Weiss Ratings downgraded shares of Cencora from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 30th. Evercore set a $360.00 target price on shares of Cencora in a research note on Wednesday, April 8th. Bank of America boosted their price target on Cencora from $280.00 to $285.00 and gave the company a “neutral” rating in a report on Wednesday, June 24th. Morgan Stanley set a $342.00 price target on Cencora in a research note on Friday, May 8th. Finally, UBS Group raised their price objective on Cencora from $410.00 to $412.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Eleven analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $367.75.

Cencora Trading Down 1.9%

NYSE COR opened at $312.58 on Friday. Cencora, Inc. has a 12 month low of $244.82 and a 12 month high of $377.54. The company has a 50-day moving average of $288.61 and a 200-day moving average of $315.62. The company has a debt-to-equity ratio of 3.40, a current ratio of 0.95 and a quick ratio of 0.59. The company has a market cap of $60.82 billion, a P/E ratio of 23.97, a P/E/G ratio of 1.77 and a beta of 0.58.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $4.75 earnings per share for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company had revenue of $78.36 billion for the quarter, compared to analysts’ expectations of $81.09 billion. During the same quarter in the previous year, the company earned $4.42 earnings per share. The company’s revenue was up 3.9% on a year-over-year basis. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. As a group, equities analysts predict that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Friday, May 15th were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, May 15th. This represents a $2.40 dividend on an annualized basis and a yield of 0.8%. Cencora’s dividend payout ratio (DPR) is currently 18.40%.

Cencora announced that its board has approved a share repurchase program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to purchase up to 3.9% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.

Insiders Place Their Bets

In related news, Director Lauren M. Tyler purchased 550 shares of the business’s stock in a transaction on Monday, June 22nd. The shares were bought at an average price of $270.23 per share, with a total value of $148,626.50. Following the completion of the purchase, the director directly owned 4,359 shares in the company, valued at approximately $1,177,932.57. This trade represents a 14.44% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. 0.38% of the stock is currently owned by corporate insiders.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.